Healthcare provider profile · identity verified

Thomas K Mccormick, M.D.

Family Practice · MT STERLING, KY · NPI 1952444796

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Amlodipine Besylate	Amlodipine Besylate	443	117
Losartan Potassium	Losartan Potassium	415	109
Atorvastatin Calcium	Atorvastatin Calcium	404	109
Omeprazole	Omeprazole	392	100
Levothyroxine Sodium	Levothyroxine Sodium	350	83
Rosuvastatin Calcium	Rosuvastatin Calcium	324	88
Hydrochlorothiazide	Hydrochlorothiazide	244	62
Metoprolol Succinate	Metoprolol Succinate	231	65
Pioglitazone Hcl	Pioglitazone Hcl	201	47
Duloxetine Hcl	Duloxetine Hcl	199	41
Alprazolam	Alprazolam	171	44
Gabapentin	Gabapentin	171	45
Lisinopril	Lisinopril	170	48
Metformin Hcl Er	Metformin Hcl	168	49
Escitalopram Oxalate	Escitalopram Oxalate	165	44
Pravastatin Sodium	Pravastatin Sodium	164	44
Simvastatin	Simvastatin	160	43
Pantoprazole Sodium	Pantoprazole Sodium	159	43
Pregabalin	Pregabalin	156	34
Tamsulosin Hcl	Tamsulosin Hcl	145	38
Tramadol Hcl	Tramadol Hcl	144	41
Olmesartan Medoxomil	Olmesartan Medoxomil	142	37
Prednisone	Prednisone	124	91
Furosemide	Furosemide	123	31
Zolpidem Tartrate	Zolpidem Tartrate	121	30
Metformin Hcl	Metformin Hcl	117	32
Potassium Chloride	Potassium Chloride	117	33
Trazodone Hcl	Trazodone Hcl	117	39
Diclofenac Sodium	Diclofenac Sodium	115	39
Ozempic	Semaglutide	107	15
Azithromycin	Azithromycin	100	66
Citalopram Hbr	Citalopram Hydrobromide	97	21
Montelukast Sodium	Montelukast Sodium	92	27
Clopidogrel	Clopidogrel Bisulfate	91	23
Fluticasone Propionate	Fluticasone Propionate	91	27
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	90	17
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	81	26
Jardiance	Empagliflozin	80	15
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	76	22
Albuterol Sulfate Hfa	Albuterol Sulfate	75	33
Synthroid	Levothyroxine Sodium	65	15
Clonazepam	Clonazepam	64	17
Allopurinol	Allopurinol	63	17
Ezetimibe	Ezetimibe	62	18
Meloxicam	Meloxicam	62	21
Buspirone Hcl	Buspirone Hcl	60	14
Fluoxetine Hcl	Fluoxetine Hcl	59	16
Xarelto	Rivaroxaban	59	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	57	17
Famotidine	Famotidine	55	12
Amoxicillin	Amoxicillin	53	46
Celecoxib	Celecoxib	53	13
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	51	11
Bupropion Xl	Bupropion Hcl	49	14
Venlafaxine Hcl Er	Venlafaxine Hcl	49	12
Cephalexin	Cephalexin	47	36
Irbesartan	Irbesartan	44	11
Carvedilol	Carvedilol	43	suppressed
Ondansetron Hcl	Ondansetron Hcl	43	16
Sertraline Hcl	Sertraline Hcl	42	suppressed
Cefdinir	Cefdinir	41	37
Eliquis	Apixaban	41	12
Oxybutynin Chloride	Oxybutynin Chloride	37	11
Diazepam	Diazepam	36	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	36	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	36	23
Ciprofloxacin Hcl	Ciprofloxacin Hcl	35	31
Ibuprofen	Ibuprofen	34	11
Ketoconazole	Ketoconazole	33	16
Fluconazole	Fluconazole	32	23
Glimepiride	Glimepiride	32	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	31	suppressed
Clonidine Hcl	Clonidine Hcl	31	suppressed
Januvia	Sitagliptin Phosphate	31	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	31	suppressed
Paroxetine Hcl	Paroxetine Hcl	31	suppressed
Farxiga	Dapagliflozin Propanediol	30	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	30	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	30	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	30	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	29	12
Amitriptyline Hcl	Amitriptyline Hcl	28	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	27	suppressed
Breo Ellipta	Fluticasone/Vilanterol	26	suppressed
Finasteride	Finasteride	26	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	26	suppressed
Alendronate Sodium	Alendronate Sodium	23	suppressed
Breyna	Budesonide/Formoterol Fumarate	22	suppressed
Hydralazine Hcl	Hydralazine Hcl	22	suppressed
Terazosin Hcl	Terazosin Hcl	22	suppressed
Symbicort	Budesonide/Formoterol Fumarate	21	suppressed
Ventolin Hfa	Albuterol Sulfate	21	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	20	suppressed
Lorazepam	Lorazepam	20	suppressed
Lovastatin	Lovastatin	20	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	20	suppressed
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	19	suppressed
Naproxen	Naproxen	19	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	19	suppressed
Telmisartan	Telmisartan	19	suppressed
Propranolol Hcl Er	Propranolol Hcl	18	suppressed
Ramipril	Ramipril	18	suppressed
Dropsafe Prep Pads	Alcohol Antiseptic Pads	17	suppressed
Nebivolol Hcl	Nebivolol Hcl	17	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	17	suppressed
Spironolactone	Spironolactone	16	suppressed
Cefuroxime	Cefuroxime Axetil	15	14
Colestipol Hcl	Colestipol Hcl	15	suppressed
Janumet Xr	Sitagliptin Phos/Metformin Hcl	15	suppressed
Shingrix	Varicella-Zoster Ge/As01b/Pf	15	11
Donepezil Hcl	Donepezil Hcl	14	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	14	14
Warfarin Sodium	Warfarin Sodium	14	suppressed
Amiloride-Hydrochlorothiazide	Amiloride/Hydrochlorothiazide	13	suppressed
Bumetanide	Bumetanide	13	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	13	suppressed
Humalog Kwikpen U-100	Insulin Lispro	13	suppressed
Meclizine Hcl	Meclizine Hcl	13	suppressed
Sucralfate	Sucralfate	13	suppressed
Acyclovir	Acyclovir	12	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	12	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	12	suppressed
Memantine Hcl	Memantine Hcl	12	suppressed
Nifedipine Er	Nifedipine	12	suppressed
Lansoprazole	Lansoprazole	11	suppressed
Metformin Er Gastric	Metformin Hcl	11	suppressed
Mupirocin	Mupirocin	11	suppressed
Raloxifene Hcl	Raloxifene Hcl	11	suppressed
Rizatriptan	Rizatriptan Benzoate	11	suppressed
Tradjenta	Linagliptin	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error